Blood Flow Restriction in Post-surgery Rehabilitation of Latarjet Procedure (BFR)

May 21, 2024 updated by: Arnaud Meylan, Ensemble Hospitalier de la Côte

Comparing the Effectiveness of Blood Flow Restriction Training and Traditional Resistance Training in Post-surgery Rehabilitation of Latarjet Procedure

The goal of this clinical trial is to evaluate the effects of Blood Flow Restriction (BFR) training on post-surgery rehabilitation following the Latarjet procedure in athletes aged 18-35.

The main questions it aims to answer are:

Does BFR training improve scapular belt muscle strength post-surgery? Does BFR training enhance shoulder function during rehabilitation?

Researchers will compare three groups:

BFR Group with 50% AOP [arterial occlusion pressure] compression BFR Placebo Group with 10% AOP compression Control Group

Participants will:

Perform the same four strengthening exercises twice a week Complete 16 semi-autonomous strength training sessions over 8 weeks Undergo isokinetic and isometric strength tests, shoulder mobility assessments, and complete self-assessment questionnaires.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: 18-35 years
  • Indication for shoulder stabilization surgery using the Latarjet procedure (documented anterior dislocations with proof of emergency reduction, with or without hypermobility and confirmation of traumatic capsulo-ligamentous injury by MRI).
  • Regular exercise (min. 1x / week)
  • Signed the informed consent form for the study.

Exclusion Criteria:

  • Pregnant or breast-feeding women
  • Active oncological disease under treatment. (Patient with stable oncological disease eligible)
  • Adverse events during the 6-week post-operative period such as:-Fracture/displacement of the reconstructed bone-Luxation of the operated shoulder-Requirement for emergency hospitalization
  • History of deep vein thrombosis/pulmonary embolism
  • Inability to follow study procedures, due to language problems, psychological disorders, dementia.
  • Need for skin grafting following shoulder stabilization surgery
  • Coronary heart disease
  • Unstable hypertension
  • Peripheral vascular disease
  • Hypercoagulable states (blood coagulation disorders)
  • Left ventricular dysfunction
  • Hemophilia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Patient will not use BFR
Placebo Comparator: Placebo 10% of pressure for arterial occlusion
Patient will use BFR sub optimally as described in the literature

Participants undergoing shoulder instability surgery (Latarjet procedure) by a single surgeon will receive standard physiotherapy (2 sessions per week) before being randomized into 3 groups at their 6th postoperative week check-up:

Group 2) BFR Group with 10% AOP compression

Group 2 will perform a 30-minute strengthening session twice weekly during postoperative weeks 7 to 14. They will do 4 exercises, completing 4 sets with 30-second rest intervals and 1 minute between exercises, following 15-15-15-15 at 70% 1RM

Exercise :

External rotation with pulley/band Internal rotation with pulley/band Frontal elevation with hyperpronation Diagonal abduction-external rotation with pulley/band

BFR training will use the MadUp© system, placing the band proximally on the operated arm, with a central unit continuously monitoring and calibrating arm pressure.

Experimental: Interventional 50% of pressure for arterial occlusion
Patient will use the minimal pressure of 50% of arterial occlusion known to be effective in the literature

Participants undergoing shoulder instability surgery (Latarjet procedure) by a single surgeon will receive standard physiotherapy (2 sessions per week) before being randomized into 3 groups at their 6th postoperative week check-up:

Group 1) BFR Group with 50% AOP compression

Group 1 will perform a 30-minute strengthening session twice weekly during postoperative weeks 7 to 14. They will do 4 exercises, completing 4 sets with 30-second rest intervals and 1 minute between exercises, following 30-15-15-15 at 40% 1RM (repetition maximum)

Exercise :

External rotation with pulley/band Internal rotation with pulley/band Frontal elevation with hyperpronation Diagonal abduction-external rotation with pulley/band

BFR training will use the MadUp© system, placing the band proximally on the operated arm, with a central unit continuously monitoring and calibrating arm pressure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isokinetic strength
Time Frame: Preoperative and at 14 weeks postoperative
Concentric peak torque (Nm) IR-ER at 60°/sec
Preoperative and at 14 weeks postoperative
Isokinetic strength
Time Frame: Preoperative and at 14 weeks postoperative
Concentric peak torque (Nm) IR-ER at 240°/sec
Preoperative and at 14 weeks postoperative
Isokinetic strength
Time Frame: Preoperative and at 14 weeks postoperative
Eccentric peak torque (Nm) IR-ER at 60°/sec
Preoperative and at 14 weeks postoperative
Isokinetic strength
Time Frame: Preoperative and at 14 weeks postoperative
Concentric ratio (ER conc 60°/ IR conc 60°)
Preoperative and at 14 weeks postoperative
Isokinetic strength
Time Frame: Preoperative and at 14 weeks postoperative
Cocking gesture ratio (IR exc 60° /ER conc 240°)
Preoperative and at 14 weeks postoperative
Isometric strength
Time Frame: Preoperative and at 14 weeks postoperative
Flexion in the scapular plane (Nm)
Preoperative and at 14 weeks postoperative
Isometric strength
Time Frame: Preoperative and at 14 weeks postoperative
Athletic shoulder test (positions I, Y, T) (Nm)
Preoperative and at 14 weeks postoperative
Isometric strength
Time Frame: Preoperative and at 14 weeks postoperative
Grip test (Nm)
Preoperative and at 14 weeks postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder mobility
Time Frame: Preoperative and at 14 weeks postoperative
Flexion
Preoperative and at 14 weeks postoperative
Shoulder mobility
Time Frame: Preoperative and at 14 weeks postoperative
Abduction
Preoperative and at 14 weeks postoperative
Shoulder mobility
Time Frame: Preoperative and at 14 weeks postoperative
Internal rotation at 90° abduction
Preoperative and at 14 weeks postoperative
Shoulder mobility
Time Frame: Preoperative and at 14 weeks postoperative
External rotation at 90° abduction
Preoperative and at 14 weeks postoperative
Shoulder mobility
Time Frame: Preoperative and at 14 weeks postoperative
Scapular dyskinesis test (SDT)
Preoperative and at 14 weeks postoperative
Scapular girdle stability
Time Frame: Preoperative and at 14 weeks postoperative
Modified closed kinetic upper extremity stability test
Preoperative and at 14 weeks postoperative
Scapular girdle stability
Time Frame: Preoperative and at 14 weeks postoperative
Shoulder Instability Return to Sport Index (SIRSI)
Preoperative and at 14 weeks postoperative
Scapular girdle stability
Time Frame: Preoperative and at 14 weeks postoperative
Western Ontario Shoulder Instability Index (WOSI)
Preoperative and at 14 weeks postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Bauer Stefan, MD, EHC Morges

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 10, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

May 16, 2024

First Submitted That Met QC Criteria

May 21, 2024

First Posted (Actual)

May 28, 2024

Study Record Updates

Last Update Posted (Actual)

May 28, 2024

Last Update Submitted That Met QC Criteria

May 21, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Dislocation

Subscribe